Lumera NGS Profile | Solid Tumor Profiling

Include 1 H&E slide if available
*We also accept core needle biopsies

Also accepted

10 Unstained Slides

4-5 micron sections

Close up of hand holding pathology slide.

Comprehensive Analysis, Meaningful Results

Our depth of knowledge of cancer grows every day, and with it comes new methods to improve patient outcomes. Fulgent Oncology's comprehensive genomic profiling provides analysis for therapeutically relevant alterations as well as those being studied in current and upcoming clinical trials.

Our team creates each report considering the mutational status of all tested genes, resulting in personalized results with recommendations for approved therapies, counter-indicated therapies, off-label options, and active trials. With this powerful tool in hand, patients and care teams are armed with the best information possible to treat and manage cancer.

Simultaneous analysis of DNA and RNA

Optimal detection of fusion genes for solid tumor profiling

Competitive detection of a broad range of variant types

SNVs, Amplifications, Gene Fusions

Germline mutation testing available

Parallel assessment of hereditary cancer risk

How It Works

For Solid Tumor Testing

Place an order

Order on the portal or download and fill out our paper requisition.

Fulgent will procure the sample

Our logistics team will initiate collection immediately upon order receipt and keep your team informed throughout.

Receive your report

All reports will be available for download in your portal within 10 business days.

A woman smiling in a call with headphones.

Ready to learn more?

Connect with our experts to learn more about how we can help.

Get in Touch

Lumera™ NGS Profile

Comprehensive Analysis, Meaningful Results

How It Works

Ready to learn more?